5-methyl-2'-fluoroarauracil F-18
- Generic Name
- 5-methyl-2'-fluoroarauracil F-18
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H13FN2O5
- CAS Number
- 241144-93-4
- Unique Ingredient Identifier
- J932A2CDQO
- Background
5-methyl-2'-fluoroarauracil F-18 is under investigation in clinical trial NCT02809690 (18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-02-12
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 10
- Registration Number
- NCT04752267
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
- First Posted Date
- 2016-06-22
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 18
- Registration Number
- NCT02809690
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath